Published in Scand J Infect Dis Suppl on January 01, 1980
"Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol (1966) 9.65
Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol (1976) 3.13
Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol (2001) 2.86
Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem (1994) 2.62
Prevalence of nine different micro-organisms in the female genital tract. A comparison between women from a venereal disease clinic and from a health control department. Br J Vener Dis (1979) 2.52
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest (2004) 2.48
Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol (1978) 2.37
Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun (1974) 2.34
Protein A mutants of Staphylococcus aureus. J Bacteriol (1971) 2.32
Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest (1999) 2.27
"Protein A" from Staphylococcus aureus. 3. Reaction with rabbit gamma-globulin. J Immunol (1967) 2.22
Standardization of Cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest Suppl (2008) 2.11
Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature (1989) 2.08
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology (1974) 2.08
Structure and expression of the human cystatin C gene. Biochem J (1990) 2.07
Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis (1974) 2.06
Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother (1977) 2.04
Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem (1986) 2.03
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med (2000) 1.96
Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus. Acta Pathol Microbiol Scand (1969) 1.86
Group B streptococci in venereal disease clinic patients. Br J Vener Dis (1975) 1.82
The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest (1985) 1.81
Protein A from Staphylococcus aureus. VII. Physicochemical and immunological characterization. Acta Pathol Microbiol Scand (1969) 1.74
Effects of staphylococcal protein A on heat labile opsonins. J Immunol (1974) 1.73
Why Britain can't afford informed consent. Hastings Cent Rep (1985) 1.73
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J (1986) 1.71
Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest (1996) 1.70
Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand (1985) 1.65
Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci (1974) 1.62
Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem (1987) 1.61
Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol (1989) 1.57
The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun (1984) 1.56
Erythromycin-resistant Campylobacters. Lancet (1978) 1.56
Studies in venereal disease. I. Isolation of L-phase organisms of N. gonorrhoeae from patients with gonorrhoea. Br J Vener Dis (1972) 1.55
Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci U S A (1982) 1.55
Low-level cadmium exposure and osteoporosis. J Bone Miner Res (2000) 1.53
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol (1997) 1.50
FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron (2000) 1.50
Renal impairment after hip or knee arthroplasty. Urinary excretion of protein markers studied in 59 patients. Acta Orthop Scand (1997) 1.49
Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett (1988) 1.47
Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Scand J Infect Dis (1990) 1.46
Breach of confidence: anonymised information. R. v. Department of Health ex parte Source Informatics Ltd. Med Law Rev (2000) 1.43
A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol (1988) 1.43
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39
Protein A from Staphylococcus aureus. VI. Reaction with subunits from guinea pig gamma-1- and gamma-2-globulin. J Immunol (1968) 1.39
Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother (1979) 1.38
Influence of normal human serum on the determination of trichomonicidal drug concentrations. Br J Vener Dis (1972) 1.35
Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett (1987) 1.34
Many bacterial species bind human IgD. J Immunol (1979) 1.34
Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation. Br J Vener Dis (1974) 1.33
Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis (1986) 1.33
THE EFFECT OF EXERCISE ON RENAL PLASMA FLOW IN NORMAL MALE SUBJECTS. J Clin Invest (1948) 1.33
4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother (1987) 1.33
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem J (1986) 1.32
Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet (1988) 1.31
Metronidazole-resistant Trichomonas vaginalis. Br J Vener Dis (1979) 1.28
Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br J Vener Dis (1974) 1.28
Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect (2011) 1.27
Studies of the alternate pathway in chelated serum. J Lab Clin Med (1975) 1.26
Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun (1991) 1.25
Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol (1990) 1.25
Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine (2000) 1.25
New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int Suppl (1994) 1.25
Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest (1997) 1.24
Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob Agents Chemother (1986) 1.24
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J (1991) 1.22
Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol (1990) 1.22
Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother (1987) 1.21
Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun (1991) 1.20
Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis (1985) 1.20
Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol (1986) 1.19
"Protein A" from Staphylococcus aureus. IV. Production of anaphylaxis-like cutaneous and systemic reactions in non-immunized guinea-pigs. J Immunol (1968) 1.18
Protein D, the immunoglobulin D-binding protein of Haemophilus influenzae, is a lipoprotein. Infect Immun (1992) 1.18
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates. Scand J Infect Dis (1985) 1.16
Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do. Antimicrob Agents Chemother (1990) 1.16
Effect of normally occurring rabbit antibodies on fluorescent-antibody reactions. J Bacteriol (1966) 1.15
Antimicrobial susceptibility of group B streptococci. Eur J Clin Microbiol (1986) 1.14
Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med (1984) 1.13
Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci U S A (1986) 1.13
DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics (1994) 1.13
Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem (1995) 1.11
Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model. Infect Immun (1994) 1.10
Tetracyclines and host-defense mechanisms. Antimicrob Agents Chemother (1973) 1.10
Enzyme-linked immunosorbent assay (ELISA) for antibodies against Campylobacter jejuni, and its clinical application. Acta Pathol Microbiol Immunol Scand B (1982) 1.09
Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int (2001) 1.09
Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest (2002) 1.08
Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest (1995) 1.08
Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest (1996) 1.08
Isolation and some properties of an IgG Fc-binding protein from group A streptococci type 15. Int Arch Allergy Appl Immunol (1982) 1.08
Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Scand J Gastroenterol (1997) 1.07
Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Scand J Clin Lab Invest (1994) 1.07
Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils. Scand J Clin Lab Invest (2007) 1.07
Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol (1999) 1.06
Sexually-transmitted diseases in women. Br J Vener Dis (1974) 1.06
Structural studies of cysteine proteases and their inhibitors. Acta Biochim Pol (2001) 1.05